Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology APIs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116354976A reveals a novel binary solvent purification method for camptothecin derivatives, achieving over 99% purity without column chromatography for reliable supply.
Patent CN1075718A reveals a novel metal alkoxide route for Taxol synthesis, offering high stereoselectivity and cost reduction in API manufacturing for global supply chains.
Novel synthesis of benzimidazole compound (I) via late-stage Suzuki coupling. Reduces cost and improves scalability for oncology intermediates.
Patent CN102351870A reveals a novel benzacridine synthesis route targeting c-myc DNA, offering scalable production and cost-effective API intermediate manufacturing solutions.
Patent CN109575109B reveals a novel fragment condensation method for Degarelix, offering significant cost reduction and high purity for reliable peptide API supply chains.
Patent CN101712708A reveals a scalable Decitabine synthesis using pivaloyl protection, eliminating chromatography for significant cost reduction and high purity.
Patent CN110981800A reveals a novel low-temperature route for Lenvatinib intermediates using ZnO catalysis, offering significant cost reduction and supply chain reliability for pharma manufacturing.
Patent CN102464702A reveals a high-purity Boc-solid phase synthesis for Leuprorelin Acetate, offering superior environmental safety and supply chain reliability for pharmaceutical manufacturers.
Novel room-temperature crystallization process for Pemetrexed Disodium ensures high purity and stability. Ideal for reliable pemetrexed disodium supplier partnerships.
Analysis of CN103254182A reveals a streamlined Afatinib synthesis via aniline condensation, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN102775389A details a robust 3-step synthesis for kinase inhibitors. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN102617677A details a high-yield route for Gemcitabine HCl using Reformatsky reaction, offering cost reduction and scalability for API manufacturers.
Novel route for Gemcitabine HCl with high yield and purity. Reduces steps and improves scalability for API manufacturing.
Novel BOC protection strategy and custom Mitsunobu reagent enhance purity and yield for commercial API manufacturing.
Novel nickel-catalyzed method for 1,2,6,7-tetrahydrocamptothecin production. Reduces cost and improves selectivity compared to traditional platinum methods.
Patent CN101558051A reveals a high-yield docetaxel synthesis using nitro-benzoyl protection, offering significant cost reduction and supply chain reliability for API manufacturers.
Advanced preparation method for Cabazitaxel using safe methylation reagents and ambient temperatures, offering significant cost reduction in API manufacturing.
Patent CN115477653A reveals a novel 4-step route for Trilaciclib intermediates, eliminating palladium catalysts for significant cost reduction in API manufacturing.
Patent CN106046089A reveals a cobalt-catalyzed route for Decitabine. Achieves high beta-selectivity and purity for reliable pharmaceutical intermediate supply chains.
Novel preparation method reduces toxic reagents and improves yield for pazopanib manufacturing supply chain efficiency.